CompletedNot Applicable

Cardiovascular Safety After Continuous Ketamine Infusion

Colombia300 participantsStarted 2017-07-01

Plain-language summary

Observational study that evaluate the cardiovascular and neuropsychiatric side effects of ketamine analgesic infusions for acute pain

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients older than 18 years old * Acute and Postoperative pain * Ketamine infusion at 0.15 mg/kg/h or below Exclusion Criteria: * Cognitive disfunction psychiatric illness * Acute cardiovascular disease * Anemia with Hb less than 7 g/dl * Decompensated hyperthyroidism * Low cardiac output * Incomplete medical history

What they're measuring

Tachycardia

Timeframe: 2 days

Hypertension

Timeframe: 2 days

Trial details

NCT IDNCT03979105

SponsorUniversidad de Antioquia

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-11-01

View on ClinicalTrials.gov More Pain trials